Amarin Corp PLC/ US0231112063 /
2024-05-03 10:00:00 PM | Chg. -0.0080 | Volume | Bid1:19:12 AM | Ask1:19:12 AM | High | Low |
---|---|---|---|---|---|---|
0.9100USD | -0.87% | 464,012 Turnover: 385,690.6770 |
0.9013Bid Size: 300 | 0.9199Ask Size: 100 | 0.9340 | 0.8911 |
GlobeNewswire
04-24
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate P...
GlobeNewswire
04-15
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
GlobeNewswire
04-08
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
GlobeNewswire
04-06
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular...
GlobeNewswire
04-03
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
GlobeNewswire
03-25
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American ...
GlobeNewswire
02-29
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
02-15
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February...
GlobeNewswire
01-10
Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For ...
GlobeNewswire
2023-12-04
Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Oth...
GlobeNewswire
2023-11-12
New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Red...
GlobeNewswire
2023-10-31
Amarin Appoints Jonathan Provoost Executive Vice President, Chief Legal & Compliance Officer
GlobeNewswire
2023-10-26
Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent ethyl) and Subgroups from the REDUCE-IT Land...
GlobeNewswire
2023-10-19
Amarin to Report Third Quarter 2023 Financial Results and Host Conference Call on November 1, 2023
GlobeNewswire
2022-03-22
CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update